Filing Details
- Accession Number:
- 0001209191-18-033787
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-29 16:12:35
- Reporting Period:
- 2018-05-24
- Accepted Time:
- 2018-05-29 16:12:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 924717 | Surmodics Inc | SRDX | Surgical & Medical Instruments & Apparatus (3841) | 411356149 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286125 | W Charles Olson | 9924 West 74Th Street Eden Prairie MN 55344 | Senior Vp Of Bus Dev, Med Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-05-24 | 18,760 | $48.48 | 33,467 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-24 | 1,240 | $49.39 | 32,227 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 800 | Indirect | By IRA |
Footnotes
- Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
- Reflects the weighted average price of 18,760 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 24, 2018 with sale prices ranging from $48.25 to $49.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 1,240 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 24, 2018 with sale prices ranging from $49.30 to $49.425 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
